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Aim: To evaluate vestibular evoked myogenic potentials
in patients with multiple sclerosis as method of diagnostic
support. Study design: Case-control. Material and
Method:  We studied a group of normal individuals (n=15)
and a Studied group (n=15) that comprised patients with
diagnosis of multiple sclerosis. Both groups were submitted
to vestibular evoked myogenic potential exam. In each ear
it was applied 200 stimuli by clicks and repeated for 2
consecutive cycles with the purpose of evaluating
reproducibility. The active electrode of surface was put on
the superior S‡of sternocleidomastoid muscle and the
reference electrode on the anterior border of the clavicle.
The individuals were instructed to rotate theirs head to the
opposite side to the stimulated ear. Results: Vestibular
evoked myogenic potential responses were prompt,
reproducible and biphasic. The latency of wave P1 and N2
and P1-N2 amplitude showed a higher value in the studied
group when compared with the normal group. There was
no significant difference when the ears were compared in
P1 and N2 amplitude. We noticed that individuals with
multiple sclerosis showed no response in 30% of the cases.
In evaluating the individuals of the Studied group with
otoneurology symptoms and compared with individuals
without symptoms, it was observed that P1 and N2 latencies
and P1-N2 amplitude were higher in symptomatic cases.
Conclusion: Vestibular evoked myogenic potential was
considered a good method of diagnostic support of
vestibulospinal tract in cases of multiple sclerosis.
Key words: auditory evoked potentials,
vestibular function exam, multiple sclerosis/ diagnosis.
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INTRODUCTION
Vestibular evoked myogenic potentials (VEMP) is a
test that assesses vestibulospinal pathway from the sacculus
macula. VEMP acoustic stimulus is evoked by clicks presented
through headsets. The macula is activated by sound stimulus,
generating an electrical potential that goes through the
pathway of the inferior vestibular nerve, lateral vestibular
nerve, vestibulospinal tract and finally, ipsilateral motor
neuron of neck muscle 1. Vestibular nuclei are located in the
pons, placed on the floor of the IV ventricle, and they are
divided into: medial, inferior, lateral and superior.
Vestibulospinal tract has descending fibers from the lateral
vestibular nucleus.
Some authors studied evoked myogenic responses
with active surface electrode placed on the inion and stated
that the response was mediated by the vestibular system
²¸ ³. As time went by, studies started to place surface
electrodes on the sternocleidomastoid muscle 4-17.
According to articles published in the literature, VEMP
is a test that assesses brainstem damage or lesions that affect
vestibulospinal tract, such as the case of multiple sclerosis
(MS) 1, 18. MS is an inflammatory demyelinizing disease of
central nervous system (CNS) of autoimmune etiology.
However, it is a disease with multifactorial etiology, in which
the association of genetic predisposition and external factors
would be determining for triggering immune events related
to inflammatory and demyelinizing process of CNS.
Epidemiological studies showed heterogeneous distribution
of the disease in the world and incidence of 0.1% in countries
of moderate temperature. In tropical countries, such as Brazil,
the disease is rare, but recent data reported high incidence
in Caucasian and African-Brazilian subjects 19.
As to diagnosis, there is evidence of two or more
lesions in CNS white matter in imaging exams, preferably
within one month of interval between symptoms, in patients
aged 15 to 50 years. Many patients experience clinical
recovery from acute episodes and progress to remission
stages. Lesions in the CNS white matter may not be
manifested by symptoms and therefore, they may be
diagnosed only through specific diagnostic tests 20.
In the past, the diagnosis of MS was based on clinical
data, but as a result of technology advance, there has been
an increase in early diagnosis. The most used tests are
magnetic resonance imaging (MRI), evoked potentials (EP),
and analysis of immunoglobulin in cerebrospinal fluid (CSF).
MRI and EP provide information on symptomatic and
asymptomatic stages, and on atypical characteristics. CSF
analysis reveals information on the inflammatory process.
Neuroimaging, through head and spinal cord MRI, is
particularly important in the diagnosis and progression of
the disease. Good clinical history, physical examination and
clinical evolution are essential to understand the disease, as
shown by Poser and McDonald criteria 21,22. Patients with MS
present different otoneurological symptoms. The most
common complaint is dizziness, more specifically imbalance.
The next most common complaints are ear fullness, tinnitus
and vertigo 22.
According to the above-reported, EP are indicated
for diagnosis, meaning that VEMP could be an additional
diagnostic method for investigation in cases of MS. Therefore,
we decided to apply VEMP in subjects with diagnosis of MS.
It is an objective, non-invasive and easy to perform test. It is
not uncomfortable and patients do not have to make physical
efforts.
OBJECTIVES
1. To assess responses to VEMP in patients with MS and
compare them to the control group.
2. To correlate otoneurological complaints with results of
latency and amplitudes in VEMP.
3. To demonstrate that VEMP is a good method for the
assessment of vestibulospinal tract in patients with MS.
MATERIAL AND METHOD
VEMP study started with the control group comprising
15 subjects. The division of Neurology, IAMSPE, referred to
the division of Otorhinolaryngology, 15 patients with diagnosis
of MS. To diagnose MS, we relied on the criteria set forth by
Poser and McDonald21. Both criteria systems are based on
number of crises, high resolution computed tomography
(HRCT) and CSF and EP affections. The second system is
complemented by MRI findings.
The inclusion criteria were: subjects in the control
group without otoneurological complaints and in the studied
group, subjects with confirmed diagnosis of MS. The exclusion
criteria for both groups were: malformation of pinna and
external auditory canal and limitation of neck rotation
movement.
Before VEMP, patients with MS and subjects in the
control group were submitted to clinical history and ENT
physical examination. To perform VEMP, we used device
Nihon Khoden programmed to middle-latency evoked
potential. Stimuli were sent through headsets brand Elega
type DR 531.
After skin cleaning with the appropriate material,
surface electrodes were placed on the following positions:
active, on the upper 1/3 of sternocleidomastoid muscle,
reference electrode, on the anterior margin of ipsilateral
clavicle, and ground electrode, on the forehead. A small
amount of electrolytic material was applied to the surface
of the electrode and fixed with adhesive tape (Figure 1).
Patients were instructed to sit down on a chair and rotate
the head contralaterally to the stimulated ear. The contraction
of muscle was maintained thanks to the cooperation of
patients in maintaining the same position during the test.
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To perform VEMP we used sound stimuli presented
as rarefaction clicks of 0.1ms of duration with 5ms/div and
frequency of 2Hz; 200 stimuli were applied to each ear and
repeated three consecutive times at 95 dB HL. All responses
were filtered between 20 and 1000 Hz.
VEMP response was obtained after monoaural
stimulation, including masking applied to stimulus intensity
minus 40 dB HL. VEMP tracings were biphasic positive-
negative P1-N2 waves.
To analyze data, we used the following statistical
methods: t-independent; McNemar test; chi-square test, t-
paired test. The level of significance was 5% (p<0.5).
RESULTS
The mean age of control group was 32.8 years, with SD
of 7.18 years (n=15). The Studied group presented mean of
39.3 years with SD of 11.9 years (n=15). There was no statistically
significant difference between the groups (Table 1).
As to absence or presence of responses in the studied
group comparing ear side, we found 26.7% of absence of
right ear responses against 33.3% on the left; 73.3% of
presence of right side responses against 66.7% on the left
(Chart 1). There were no statistically significant differences
between the ears.
In Chart 2, we observed distribution of presence and
absence of symptoms comparing the ears in the studied
group. There was no statistically significant difference
between the ears.
Upon comparing the results of VEMP between the
groups, we observed that 30% of the studied group presented
absence of responses (Table 2). Therefore, we found
statistically significant value (observed value = 10.59).
Chi-square test assessed presence and absence of
symptoms between the groups by comparing them with
VEMP results (Table 3). There was no statistically significant
difference. Even though non-significant, the group with
presence of symptoms presented higher number of absent
responses (34.8%), indicating a trend that could be better
assessed with a larger studied group.
Using t-paired test, we analyzed the statistics of am-
plitude P1-N2, wave P1 and wave N2 in VEMP in the control
group and studied group, comparing the right ear with the
left ear. There was no statistically significant difference in all
studied cases (Tables 4 to 9).
The control group was compared to the studied group
by assessing the statistics of amplitude of P1-N2, wave P1
and wave N2 applying t-independent test. In the three
studied situations, the studied group presented higher value
in VEMP responses than the control group, which was
considered statistically significant (Tables 10, 11 and 12).
We assessed mean value of amplitude P1-N2, wave
P1 and N2 in subjects with presence of symptoms and
compared the group of patients with absence of symptoms.
Figure 1. Position of the patient in lateral rotation and position of
reference and ground surface electrodes
Chart 1. Distribution concerning absence and presence
of responses in patients with MS comparing both ears
(N=15).
Left side
Absent Present Total
Absent 01 (6.7%) 04 (26.7%) 05 (33.3%)
Presente 03 (20%) 07 (46.7%) 10 (66.7%)
Total 04 (26.7%) 11 (73.3%) 15 (100%)
Test: Mc Nemar
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Chart 2. Distribution concerning presence and absence of
symptoms in patients with MS comparing both ears.
Right side
Absent Present Total
Absent 02 (13.3%) 01 (06.7%) 03 (20.0%)
Present 02 (13.3%) 10 (66.7%) 12 (80.0%)
Total 04 (26.7%) 11 (73.3%) 15 (100%)
 Test: Mc Nemar P=1.000
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ft 
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de
Table 1. Distribution according to age in years in the control
group and studied group.
Statistics Control group Studied group
Mean 32.8 39.3
Standard deviation 7.18 11.9
Total 15 15
t-dependent test
p= 0.079
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In the three situations, the group of subjects with symptoms
presented mean value of VEMP response higher than the
group without symptoms (Tables 13, 14 and 15).
DISCUSSION
In the study described here, all subjects presented
diagnosis of MS, defined by the division of clinical neurology,
IAMSPE, based on the criteria by Poser and McDonald21,22. In
1868, Charcot described the first set of diagnostic criteria for
MS. Other criteria were published in 1954, Allison-Millar; 1961,
Schumaker; 1972, McAlpine; finally, in 1983, Poser, and 2002,
McDonald. The first criteria were based on subjective
assessment of the researcher. The two last criteria systems
were based on clinical impressions, laboratory analyses,
neuroimaging and evoked potentials. However, to define
the diagnosis it is necessary to associate the clinical history
with physical examination and disease progression.21
Table 2. Distribution concerning absence and presence of
VEMP responses comparing the control group and MS
group.
Wave Control Studied Total
Group Group
Absent  00 (0%)  09 (30.0%)  09 (15.0%)
Present  30 (100.0%)  21 (70.0%)  51 (85.0%)
Total  30 (100.0%)  30 (100.0%)  60 (100.0%)
Test: Chi-square
Observed value: 10.59*
Critical value: 3.84
Table 3. Distribution concerning absence and presence of
symptoms in the group with MS compared to VEMP responses.
Otoneurological Symptoms
 +  -  Total
Wave  N (%)  N (%)  N (%)
Absent  08 (34.8%)  01 (14.3%)  09 (30.0%)
Present  15 (65.2%)  06 (85.7%)  21 (70.0%)
Total  23 (100.0%)  07 (100.0%)  30 (100.0%)
Test: Chi-square
Observed value: 1.07
Critical value: 3.84
Table 4. Amplitude of wave PIN2 (µV) of the control group
comparing right and left ears.
Statistics Right side Left side
Mean 7.54 7.23
Standard deviation 5.95 4.76
Total 15 15
T-paired test
 p= 0.796
Table 5. Latency of wave P1 (ms) in VEMP in the control group
comparing right and left ear.
Statistics Right side Left side
Mean 11.12 10.76
Standard deviation 1.64 1.59
Tamanho 15 15
T-paired test
p= 0.344
Table 7. Amplitude of wave PIN2 (µ V) in the MS group
comparing right and left ears.
Statistics Right side Left side
Mean 12.17 13.30
Standard deviation 6.50 3.63
Total 7 7
T-paired test
p= 0.759
Table 6. Latency of wave N2 (ms) in VEMP in the control group
comparing right and left ears.
Statistics Right side Left side
Mean 15.15 14.86
Standard deviation 2.51 2.85
Total 15 15
T-paired test
p=0.613
Table 8. Latency of wave P1 (ms) in the MS group comparing
right and left ears.
Statistics Right side Left side
Mean 13.40 13.49
Standard deviation 2.87 1.77
Total 7 7
T-paired test
p=0.944
Table 9. Latency of wave N2 (ms) in the MS group comparing
right and left ears.
Statistics Right side Left side
Mean 18.64 17.84
Standard deviation 2.67 1.27
Total 7 7
T-paired test
p=0.514
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Table 10. Amplitude P1N2 (µV) comparing control group and
MS.
Statistics Control Studied
Mean 7.39 10.94
Standard deviation 5.30 5.39
Total 30 21
T-independent test
p=0.023
Table 11. Latency of wave P1 (ms) comparing control group
and MS group.
Statistics Control Studied
Mean 10.94 12.78
Standard deviation 1.60 2.41
Total 30 21
T-independent test
p=0.005*
Table 12. Latency of wave N2 (ms) comparing the control group
and MS group.
Statistics Control Studied
Mean 15.00 17.07
Standard deviation 2.64 2.73
Total 30 21
T-independent test
 p=0.009*
Table 13. Amplitude P1N2 (µV) comparing group and presence
or absence of symptoms.
Statistics + -
Mean 12.37 7.34
Standard deviation 5.56 2.79
Total 15 6
T-independent test
p=0.013*
Table 15. Latency of wave N2 (ms) comparing the group with
presence and absence of symptoms.
Statistics + -
Mean 18.05 14.63
Standard deviation 2.26 2.34
Total 15 6
T-independent test
p=0.006*
When observing a study of middle latency potential,
we observe responses within a period of 12 to 50 ms. In
order to study the middle latency, we used VEMP in the
following parameters: surface electrodes were placed on
sternocleidomastoid muscle because responses are more
consistent and homogenous, in addition to being a more
practical and comfortable method to the patients 3-8,
rarefaction clicks, frequency of 2Hz and pass filter that ranged
from 20 to 1000Hz. There is variation of frequency range
described in the literature. However, lowest frequency equal
or below 5Hz is the best and most widely used by the studied
literature4,6-8,10,12,13,15,17,23.
Reproducibility is an important factor when conducting
evoked potential test and it is extremely valuable both
immediately and in the long-run. The immediate form
confirms the existence of integrity of vestibulospinal tract
and the long-run form evidences disease progression and its
prognosis 8,11,24.
Table 14. Latency of wave P1 (ms) comparing the group with
presence and absence of symptoms.
Statistics + -
Mean 13.49 11.02
Standard deviation 2.24 1.99
Total 15 6
T-independent test
 p=0.030*
As to results, we observed that when comparing the
right ear with the left ear, the correlation between absence
and presence of responses and correlation between absence
and presence of symptoms in VEMP did not result in
significant difference. Therefore, we could count the ears as
isolated normal and not as subjects (Figure 2).
Otoneurological symptoms reported by the patients
were extremely varied: hearing loss, tinnitus, ear fullness,
imbalance and sudden deafness. Patients referred imbalance
as the most frequent symptom. All patients reported these
symptoms in some phase of their lives, which could have
been sudden, unique, recurrent or progressive.
According to the literature, there are different
otoneurological manifestations that can be seen in MS
patients. High frequency of imbalance was observed in these
cases. They reported complaints of dizziness before and/or
after confirmed diagnosis of MS 18, 25, 26. They also described
some cases of sudden deafness as the first symptom of
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manifestation of the disease or as a symptom of MS episodes.
They also detected that demyelinization could be present
in the distal part of the 8th cranial nerve27-30.
In our study, we observed that in the studied group,
30% presented absence of responses (Figure 3). The
statistical value obtained (10.59) was considered significant
as a result of the critical value 3, 9. The amplitude response
P1-N2, wave P1 and wave N2 were higher in patients in the
studied group. We also observed a higher amount in
symptomatic cases in the studied group than in asymptomatic
cases.
The absence of VEMP responses was described in
patients that had been submitted to selective section of
vestibular nerve 4, in 71% of the patients with vestibular
schwannoma of the affected ear 7, and in 2 cases of post-
neurectomy vestibular schwannoma 13,14, in 7 cases of vesti-
bular schwannoma (7 out of 28 cases) in which there was
affection of inferior vestibular nerve 23, in 1 case after surgery
of cerebellopontine angle tumor 17, 69% of cerebellopontine
angle tumors 31. Absence of responses and affections of
VEMP amplitude 4, 16 could be explained as vestibulospinal
tract disorder. Vestibulospinal tract anatomy has been well
studied and explored; however, it has not managed to
quantify to what extent the vestibulospinal tract has to be
affected to cause symptoms and it is also impossible to know
the exact location of the affected site. There are other
hypotheses to justify the damage: inflammation of superior
vestibular nerve, owing to posterior and lateral semicircular
canal damage; inflammation of inferior vestibular nerve, which
affects the posterior semicircular canal and causes complete
inflammation of vestibular ganglion, which includes the su-
perior and inferior vestibular nerve 15.
Considering that there are few diagnostic tests to
assess vestibulospinal tract, VEMP is considered an important
method of investigation of this tract.
CONCLUSION
A study with 15 subjects with MS and 15 subjects in
the control group was conducted at IAMSPE and we
concluded that:
1. Latency of wave P1 and N2 and amplitude P1-N2 showed
increased values in VEMP in patients with MS when
compared to the control group.
2. There was no statistically significant difference in results
of wave P1 and N2 latency and P1-N2 amplitude in VEMP
when comparing both ears.
3. Patients with diagnosis of MS and otoneurological
symptoms presented higher frequency of VEMP affection
when compared to patients without otoneurological
symptoms.
4. VEMP was considered a good diagnostic support method
in cases of MS. In addition to being an objective test, it is
not invasive and is easy to perform.
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